M
Matthew A. Jacobs
Researcher at Boston University
Publications - 2
Citations - 1699
Matthew A. Jacobs is an academic researcher from Boston University. The author has contributed to research in topics: Internal medicine & Stage (stratigraphy). The author has an hindex of 1, co-authored 1 publications receiving 1486 citations.
Papers
More filters
Journal ArticleDOI
The spectrum of disease in chronic traumatic encephalopathy
Ann C. McKee,Thor D. Stein,Thor D. Stein,Christopher J. Nowinski,Robert S. Stern,Daniel H. Daneshvar,Victor E. Alvarez,H. J. Lee,Garth F. Hall,Sydney M. Wojtowicz,Sydney M. Wojtowicz,Christine M. Baugh,David O. Riley,Caroline A. Kubilus,Kerry Cormier,Matthew A. Jacobs,Brett Martin,Carmela R. Abraham,Tsuneya Ikezu,Robert Ross Reichard,Benjamin Wolozin,Andrew E. Budson,Andrew E. Budson,Lee E. Goldstein,Neil W. Kowall,Robert C. Cantu +25 more
TL;DR: The frequent association of chronic traumatic encephalopathy with other neurodegenerative disorders suggests that repetitive brain trauma and hyperphosphorylated tau protein deposition promote the accumulation of other abnormally aggregated proteins including TAR DNA-binding protein 43, amyloid beta protein and alpha-synuclein.
Journal ArticleDOI
MA03.04 An Integrated Deep Learning Method to Predict Lung Cancer Recurrence Risk for Resected Stage IA NSCLC
Ping Huang,Peter B. Illei,W. Franklin,P. H. Wu,Patrick M. Forde,Saeed Ashrafinia,C Hu,X. Kong,H. Khan,Harshna V. Vadvala,I.-M. Shih,Richard J. Battafarano,Matthew A. Jacobs,Y Chen,Franck Housseau,Arman Rahmim,Elliot K. Fishman,David S. Ettinger,Kenneth J. Pienta,D Wirtz,Malcolm V. Brock,Edward Gabrielson,S. Lam +22 more
TL;DR: Although several biomarkers have been found to be associated with tumor recurrence, their added value to traditional TNM staging are unclear as mentioned in this paper , however, the added value of these biomarkers to traditional NMT staging is unclear.